LIVN – LivaNova PLC
Float Short %
4.48
Margin Of Safety %
-30
Put/Call OI Ratio
0.42
EPS Next Q Diff
-0.07
EPS Last/This Y
2.69
EPS This/Next Y
0.27
Price
68.39
Target Price
73.1
Analyst Recom
1.64
Performance Q
26.96
Upside
-176.2%
Beta
0.93
Ticker: LIVN
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-01-23 | LIVN | 63.16 | 0.23 | 0.00 | 133 |
| 2026-01-26 | LIVN | 64.21 | 0.21 | 999.99 | 143 |
| 2026-01-27 | LIVN | 64.11 | 0.30 | 1.00 | 153 |
| 2026-01-28 | LIVN | 63.9 | 0.30 | 0.00 | 155 |
| 2026-01-29 | LIVN | 64.74 | 0.29 | 5.33 | 161 |
| 2026-01-30 | LIVN | 65.75 | 0.64 | 0.00 | 216 |
| 2026-02-02 | LIVN | 66.74 | 0.60 | 0.00 | 225 |
| 2026-02-03 | LIVN | 65.95 | 0.55 | 0.14 | 236 |
| 2026-02-04 | LIVN | 65.44 | 0.56 | 0.00 | 236 |
| 2026-02-05 | LIVN | 65.06 | 0.55 | 2.00 | 240 |
| 2026-02-06 | LIVN | 66.59 | 0.55 | 0.00 | 239 |
| 2026-02-09 | LIVN | 65.75 | 0.52 | 0.00 | 250 |
| 2026-02-10 | LIVN | 66.75 | 0.51 | 0.18 | 251 |
| 2026-02-11 | LIVN | 66.45 | 0.51 | 0.18 | 251 |
| 2026-02-12 | LIVN | 63.84 | 0.49 | 0.00 | 265 |
| 2026-02-13 | LIVN | 65.81 | 0.48 | 0.00 | 267 |
| 2026-02-17 | LIVN | 66.95 | 0.48 | 0.00 | 267 |
| 2026-02-18 | LIVN | 67.39 | 0.49 | 0.50 | 265 |
| 2026-02-19 | LIVN | 67.86 | 0.48 | 0.00 | 270 |
| 2026-02-20 | LIVN | 68.36 | 0.42 | 0.21 | 299 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-01-23 | LIVN | 63.11 | 0.6 | 313.6 | 3.86 |
| 2026-01-26 | LIVN | 64.18 | 0.6 | 318.7 | 3.86 |
| 2026-01-27 | LIVN | 64.06 | 0.6 | 315.3 | 3.86 |
| 2026-01-28 | LIVN | 63.88 | 0.6 | 315.1 | 3.86 |
| 2026-01-29 | LIVN | 64.69 | 0.6 | 318.1 | 3.86 |
| 2026-01-30 | LIVN | 65.77 | 0.6 | 318.9 | 3.86 |
| 2026-02-02 | LIVN | 66.71 | 0.6 | 318.6 | 3.86 |
| 2026-02-03 | LIVN | 65.96 | 0.6 | 313.5 | 3.86 |
| 2026-02-04 | LIVN | 65.43 | 0.6 | 314.4 | 3.86 |
| 2026-02-05 | LIVN | 65.02 | 0.6 | 314.6 | 3.86 |
| 2026-02-06 | LIVN | 66.58 | 0.6 | 320.2 | 3.86 |
| 2026-02-09 | LIVN | 65.77 | 0.6 | 313.5 | 3.86 |
| 2026-02-10 | LIVN | 66.73 | 0.6 | 318.5 | 3.86 |
| 2026-02-11 | LIVN | 66.45 | 0.6 | 314.9 | 3.86 |
| 2026-02-12 | LIVN | 63.89 | 0.6 | 308.6 | 3.86 |
| 2026-02-13 | LIVN | 65.89 | 0.6 | 321.6 | 3.86 |
| 2026-02-17 | LIVN | 66.96 | 0.6 | 319.0 | 3.86 |
| 2026-02-18 | LIVN | 67.41 | 0.6 | 317.0 | 3.86 |
| 2026-02-19 | LIVN | 67.89 | 0.6 | - | 3.86 |
| 2026-02-20 | LIVN | 68.39 | 0.6 | - | 3.86 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-01-23 | LIVN | -0.99 | -0.37 | 3.73 |
| 2026-01-26 | LIVN | -0.99 | -0.16 | 3.73 |
| 2026-01-27 | LIVN | -0.99 | -0.16 | 3.73 |
| 2026-01-28 | LIVN | -0.99 | -0.16 | 3.37 |
| 2026-01-29 | LIVN | -0.99 | -0.16 | 3.37 |
| 2026-01-30 | LIVN | -0.99 | -0.16 | 3.37 |
| 2026-02-02 | LIVN | -0.99 | -0.06 | 3.37 |
| 2026-02-03 | LIVN | -0.99 | -0.06 | 3.37 |
| 2026-02-04 | LIVN | -0.99 | -0.06 | 3.37 |
| 2026-02-05 | LIVN | -0.99 | -0.06 | 3.37 |
| 2026-02-06 | LIVN | -0.99 | -0.06 | 3.37 |
| 2026-02-09 | LIVN | -0.99 | 0.98 | 3.37 |
| 2026-02-10 | LIVN | -0.99 | 0.98 | 3.37 |
| 2026-02-11 | LIVN | -0.99 | 0.98 | 4.48 |
| 2026-02-12 | LIVN | -0.99 | 0.98 | 4.48 |
| 2026-02-13 | LIVN | -0.99 | 0.98 | 4.48 |
| 2026-02-17 | LIVN | -0.99 | 2.94 | 4.48 |
| 2026-02-18 | LIVN | -0.99 | 2.94 | 4.48 |
| 2026-02-19 | LIVN | -0.99 | 2.94 | 4.48 |
| 2026-02-20 | LIVN | -0.99 | 2.94 | 4.48 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
0.97
Avg. EPS Est. Current Quarter
0.81
Avg. EPS Est. Next Quarter
0.9
Insider Transactions
-0.99
Institutional Transactions
2.94
Beta
0.93
Average Sales Estimate Current Quarter
353
Average Sales Estimate Next Quarter
338
Fair Value
47.91
Quality Score
48
Growth Score
45
Sentiment Score
99
Actual DrawDown %
27.2
Max Drawdown 5-Year %
-63.5
Target Price
73.1
P/E
Forward P/E
16.56
PEG
1.69
P/S
2.77
P/B
3.23
P/Free Cash Flow
19.52
EPS
-4.01
Average EPS Est. Cur. Y
3.86
EPS Next Y. (Est.)
4.13
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-16.12
Relative Volume
1.48
Return on Equity vs Sector %
-47.8
Return on Equity vs Industry %
-36.5
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
LivaNova PLCSector: Healthcare
Industry: Medical Devices
Employees: 2900
LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products and therapies for neurological and cardiac conditions worldwide. The company operates in two segments, Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment provides cardiopulmonary products, including heart-lung machines, oxygenators, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related accessories. The Neuromodulation segment offers VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; and devices that deliver neuromodulation therapy for treating difficult-to-treat depression and drug-resistant epilepsy. The company serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its medical devices through a combination of direct sales representatives, agents, and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.
stock quote shares LIVN – LivaNova PLC Stock Price stock today
news today LIVN – LivaNova PLC stock forecast ,stock prediction 2023 2024 2025
marketwatch LIVN – LivaNova PLC yahoo finance google finance
stock history LIVN – LivaNova PLC invest stock market
stock prices LIVN premarket after hours
ticker LIVN fair value insiders trading